ADC Therapeutics S.A. (ADCT) Financials

ADCT Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 279.4 million 507.6 million
March 31, 2026 291.5 million 507.9 million
Dec. 31, 2025 323.2 million 509.0 million
Sept. 30, 2025 289.8 million 527.9 million

ADCT Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -11.8 million 4.6 million
March 31, 2026 -29.7 million 2.4 million
Dec. 31, 2025 -31.1 million 6.1 million
Sept. 30, 2025 -29.6 million 2.0 million

ADCT Net Income

No data available :(

ADCT Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 219.1 million - -
March 31, 2026 231.0 million - 991000
Dec. 31, 2025 261.3 million - 1.6 million
Sept. 30, 2025 234.7 million - 2.1 million

ADCT Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 155.0 million
March 31, 2026 154.1 million
Dec. 31, 2025 150.3 million
Sept. 30, 2025 136.4 million

ADCT Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 139 17.4 million 9.7 million 12.6 million
March 31, 2026 32000 19.9 million 9.9 million 12.7 million
Dec. 31, 2025 11580 18.2 million 15.6 million 5.9 million
Sept. 30, 2025 2186 26.8 million 14.0 million 5.0 million

ADCT Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 19.2 million 2.3 million
March 31, 2026 20.0 million 3.6 million
Dec. 31, 2025 23.1 million 1.7 million
Sept. 30, 2025 16.4 million 1.2 million

ADCT Revenue by Segment
Graph available only for paid members. Upgrade to see it.

ADCT

Price: $1.26

52 week price:
0.78
4.98

Earnings Per Share: -0.58 USD

Exchange: NYQ

Sector: Healthcare

Industry: Biotechnology

Country: Switzerland

Volume: 1.0 million

Market Capitalization: 167.3 million

Links: